Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback